DEVELOPMENT AND EVALUATION OF PHYTOSOMES OF Artemisia vulgaris L. FOR ANTICANCER ACTIVITY Authors: Sundaraganapathy R , GAYATHRI.K, KUMUDHA.D, THABSEERA.N, UVAIS.T, SUREKA.M, SURYA PRAKASH.R, VELLAISAMY.R, VYSHNA.V AND S MOHAN
ABSTRACT
Cancer is a major public health issue associated with significant death and disability. Breast
cancer is second and very common type of cancer in women worldwide. Artemisia vulgaris
L. (Mugwort), family Asteraceae, has been used to treat various diseases. Since ancient times
the Indians were used Artemisia vulgaris L. to treat imbalances that women may suffer such
as Breast cancer, Premenstrual syndrome, Dysmenorrheal, Menopause and anti-fertility. The
term “Phyto” means plant while “Some” means cell like. Phytosomes are little cell-like
structure. Phytosomes are recently introduced herbal formulation which contains
phytoconstituents that are better absorbed and as a result produce better bioavailability and
pharmacological actions. Phytosomes are novel patented technology to develop and
incorporate the standardized plant extract into phospholipids to produce lipid compatible
molecular complexes. The Phytosomes are developed from the ethanolic extract of Artemisia
vulgaris L. by anti-solvent precipitation method, characterized and evaluated for anticancer
activity.
Keywords: Artemisia vulgaris L., Anticancer, Phytosomes, Breast Cancer Publication date: 01/03/2020 https://ijbpas.com/pdf/2020/March/MS_IJBPAS_2020_4975.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2020/9.3.4975